Navigation Links
NeuroTherm Completes Acquisition of the Micron Epidural Catheter
Date:6/19/2009

WILMINGTON, Mass., June 19, /PRNewswire/ -- NeuroTherm announces the acquisition of the Micron Catheter from private owners in Palm Beach Gardens, Florida on June 17, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090217/NE70925LOGO )

"This acquisition provides the opportunity to offer our customers another exceptional product," says Larry Davis, V.P. of US Sales for NeuroTherm. NeuroTherm has an established distribution network currently selling a wide range of products to interventional pain specialists in the United States and internationally. "This is a logical expansion of our current product offering; many of our physicians have been waiting for us to provide an epidural catheter as part of our product mix," continues Davis.

The Micron Catheter is used in a procedure called Epidural Lysis of Adhesions; a common interventional pain procedure used to remove scar tissue. The scar tissue which typically result from back surgery, inflame surrounding nerves creating a source of chronic pain.

"The Micron Catheter was particularly interesting to us because of a revolutionary design that includes a continuous coil guide wire and a tip that is not a fused cap. This removes any danger of the tip breaking during procedure," says Bill Rittman, CTO of NeuroTherm. "We are excited about offering this product, along with the opportunity to improve and expand the catheter line going forward."

NeuroTherm is a leading manufacturer of products used in the field of Interventional Pain, including radio frequency generators and related consumables used in the treatment of chronic pain. The company developed the first multi-lesion generator capable of producing multiple level lesions simultaneously. NeuroTherm markets and sells RF products for use in Interventional Pain and Podiatry; Podiatrists use radiofrequency to treat pain associated with Plantar Fasciitis & Neuroma.

NeuroTherm is based in Wilmington, Massachusetts with corporate offices in London, UK and Amsterdam, NL. Additional information about NeuroTherm can be found on at www.neurotherm.com.


'/>"/>
SOURCE NeuroTherm
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The Ellis Agency, an eastern Georgie ... Foundation in a community wide charity event with the goal of bringing in support ... local woman who lives with epilepsy, recently launched a charity campaign of her own ...
(Date:7/21/2017)... ... July 21, 2017 , ... Thomas Jefferson University , ... was awarded a $300,000 grant from The Pew Center for Arts & Heritage ... and the recognition of one’s own limits among health professions students. , ...
(Date:7/21/2017)... NJ (PRWEB) , ... July 21, 2017 , ... ... has received a $5,000 grant from the C. R. Bard Foundation, ... Day Center at Somerset Hills , a service available through the nonprofit home ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) ... of life a decade after surgery, though activity levels decline over time. The ...
(Date:7/20/2017)... MA (PRWEB) , ... July 20, 2017 , ... ... form of blood and bone marrow cancer that progresses rapidly without treatment. Newly ... recommended to reduce the chance of reoccurrence and relapse. With such a ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017  BDI Group ... and patient support services organization serving specialty pharmacies, ... the launch of four significant, value-added member programs ... insights, better manage reimbursement and improve access and ... factor therapies. ...
(Date:7/10/2017)... N.C. , July 10, 2017 Locus ... Convertible Note to support the development of CRISPR-Cas3 antimicrobial ... Holdings Limited, a leading Chinese Internet services provider, and ... will advance multiple infectious disease product programs targeting antibiotic ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... July 5, 2017 Wolfmet 3D  printed tungsten collimator manufactured ... physics and manufacturing combine to progress molecular radiotherapy imaging. ... systems are unable to accurately quantify the radiation absorbed by ... regarding the success of this radiotherapy treatment has been available ... ...
Breaking Medicine Technology: